Saffron
Best for
Lift and steady your mood
Large effect, needs confirmation · 28–60 mg/day for 6–8 weeks · 3 studies , n=189
58 papers · 13 claims · 152 outcomes scored · 12 positive
Outcomes
What saffron actually does, by outcome
Each row is one outcome with effect size, evidence base, the dose that worked in trials, and time to first effect. Magnitude tiers come from native-unit MCID where available, Cohen's d otherwise.
Good days come more often and bad ones feel less heavy.
Lower intensity, fewer flares, and longer stretches of relief.
Fewer wake-ups and more unbroken hours of real rest.
Fewer dark stretches and more spontaneous positive moments through the day.
The background noise of worry, irritability, and low mood gets quieter.
Lowers the weight of sadness, low energy, and emotional numbness over weeks.
Compensates for the sunlight deficit when days get short.
When pain loosens its grip, mood follows.
The background hum of worry that colors everything gets quieter.
Quiets the health worries and body tension that build with age.
Quiets the overthinking that hijacks execution right before you compete.
Everyday pressure stops running your nervous system hot.
| Outcome | Effect | Evidence | Dose | Weeks | Rank |
|---|---|---|---|---|---|
| Lift and steady your mood Large effect, needs confirmation | | 3 RCTs n=189 | 28–60 mg | 6–8 wk | #1/20 |
| Reduce everyday pain intensity Large effect, needs confirmation | | 2 meta-analyses n=42 Meta-analyzed | 15–100 mg | 12 wk | #10/55 |
| Stay asleep through the night Likely benefit | | 4 meta-analyses n=405 Meta-analyzed | 0.6–300 mg | 4–6 wk | #2/15 |
| Lift mood and reduce negativity Promising early signal | | 2 RCTs n=169 | 28–30 mg | 6–12 wk | #2/6 |
| Reduce emotional overwhelm Promising early signal | | 2 RCTs n=144 | 28 mg | 6–12 wk | #3/7 |
| Ease depression symptoms Likely modest benefit | | 12 meta-analyses n=18k Meta-analyzed | 0.6–300 mg | 4–48 wk | #2/41 |
| Ease winter depression symptoms Likely modest benefit | | 11 meta-analyses n=18k Meta-analyzed | 15–125 mg | 4–48 wk | #2/39 |
| Ease depression tied to chronic pain Likely modest benefit | | 11 meta-analyses n=18k Meta-analyzed | 15–125 mg | 4–48 wk | #2/39 |
| Lower day-to-day anxiety Faint early signal | | 4 meta-analyses n=278 Meta-analyzed | 0.6–300 mg | 1–6 wk | #9/48 |
| Ease anxiety in older adults Faint early signal | | 4 meta-analyses n=278 Meta-analyzed | 0.6–300 mg | 1–6 wk | #9/45 |
| Reduce pre-competition anxiety Faint early signal | | 4 meta-analyses n=278 Meta-analyzed | 0.6–300 mg | 1–6 wk | #9/45 |
| Reduce daily stress Faint early signal | | 3 RCTs n=122 | 0.06–30 mg | 4–8 wk | — |
| Improve everyday quality of life Not enough research | | 3 RCTs n=151 | 15.5–30 mg | 4–6 wk | — |
Recommended Saffron products
Real products that dose Saffron where the research does, in a clean formulation, from brands we've audited. We only list ones we'd stand behind.
-
Swanson
Saffron Extract
Well dosed 60 mg/day A formulaBrand audit 69/100
-
Seeking Health
Serotonin Nutrients
Well dosed 30 mg/day A formulaBrand audit 85/100
-
Country Life
PMS Rescue
Well dosed 30 mg/day C formulaBrand audit 74/100
-
Paradise
Saffr-Tone
Well dosed 30 mg/day A formula -
Core Nutritionals
BURN Blazin' Blue Raz
Well dosed 30 mg/day C formulaBrand audit 60/100
-
Core Nutritionals
BURN Orange Mango
Well dosed 30 mg/day C formulaBrand audit 60/100
Chosen for adequate Saffron dosing vs. the studied range, a clean formulation (grade A–C), and independent brand-quality audits. Not sponsored.
Risk profile
Adverse events and known drug interactions
Safety events
Drug interactions
Co-studied with
Supplements that share evidence with saffron
-
Vitamine 40 shared outcomes · d=0.73 -
Probiotics 12 shared outcomes · d=0.23 -
Magnesium 12 shared outcomes · d=0.23 - Drug:Metformin 9 shared outcomes · d=0.38
-
Baicalin 5 shared outcomes · d=0.54
Sources
- 1. Comparing the effects of saffron, lippia, and saffron-lippia combination on anxiety among candidates for coronary angiography. (2021) ↑
- 2. Crocus Sativus for Insomnia: A Systematic Review and Meta-Analysis. (2022) ↑
- 3. Evaluation of Saffron (Crocus Sativus L) Effects on Anxiety in Hospitalized Patients with Acute Coronary Syndrome. (2023) ↑
- 4. The Effects of Combined Scutellaria and Saffron Supplementation on Mood Regulation in Participants with Mild-to-Moderate Depressive Symptoms: A Randomized, Double-Blind, Placebo-Controlled Study. (2025) ↑
- 5. Effects of Saffron Extract Supplementation on Mood, Well-Being, and Response to a Psychosocial Stressor in Healthy Adults: A Randomized, Double-Blind, Parallel Group, Clinical Trial. (2020) ↑
- 6. Effect of saffron on fluoxetine-induced sexual impairment in men: randomized double-blind placebo-controlled trial. (2012) ↑
- 7. Saffron for treatment of fluoxetine-induced sexual dysfunction in women: randomized double-blind placebo-controlled study. (2013) ↑
- 8. Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials. (2013) ↑
- 9. Comparative efficacy and safety of Crocus sativus L. for treating mild to moderate major depressive disorder in adults: a meta-analysis of randomized controlled trials. (2018) ↑
- 10. The efficacy of Crocus sativus (Saffron) versus placebo and Fluoxetine in treating depression: a systematic review and meta-analysis. (2019) ↑
Generated August 14, 2026
Related
More evidence for Saffron
Evidence guide
Saffron
NewThreads of Light: How a Royal Dye Became a Research-Backed Aid for Mood, Sleep, and Sight
Evidence guide
Apr 7, 2026
Ranking
Deep, Restful Sleep
NewBest Supplements for Deep, Restful Sleep (2026)
Evidence ranking
Mar 29, 2026
Ranking
Peripheral Neuropathy
NewBest Supplements to Ease Neuropathy Pain and Numbness (2026)
Evidence ranking
Apr 4, 2026
Ranking
Sleep Quality
NewBest Supplements to Increase Deep, Restorative Sleep (2026)
Evidence ranking
May 16, 2026
Ranking
High Blood Pressure
NewBest Supplements for Blood Pressure, Ranked by Clinical Evidence
Evidence ranking
Apr 4, 2026
Ranking
Period Cramps (Primary Dysmenorrhea)
NewBest Supplements for Period Cramps, Ranked by Clinical Evidence
Evidence ranking
Apr 4, 2026